4D Molecular Therapeutics Inc (FDMT)
26.00
+0.66
(+2.60%)
USD |
NASDAQ |
May 20, 16:00
25.98
-0.02
(-0.08%)
Pre-Market: 20:00
4D Molecular Therapeutics Total Liabilities (Quarterly): 29.32M for March 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 29.32M |
| December 31, 2023 | 32.06M |
| September 30, 2023 | 31.68M |
| June 30, 2023 | 27.36M |
| March 31, 2023 | 25.42M |
| December 31, 2022 | 30.51M |
| September 30, 2022 | 28.72M |
| June 30, 2022 | 30.42M |
| March 31, 2022 | 28.87M |
| Date | Value |
|---|---|
| December 31, 2021 | 34.38M |
| September 30, 2021 | 16.48M |
| June 30, 2021 | 14.29M |
| March 31, 2021 | 27.68M |
| December 31, 2020 | 31.94M |
| September 30, 2020 | 28.04M |
| December 31, 2019 | 131.20M |
| June 30, 2019 | 122.80M |
| December 31, 2018 | 124.56M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
14.29M
Minimum
Jun 2021
131.20M
Maximum
Dec 2019
39.48M
Average
29.32M
Median
Mar 2024
Total Liabilities (Quarterly) Benchmarks
| Ionis Pharmaceuticals Inc | 2.467B |
| NovaBay Pharmaceuticals Inc | 5.197M |
| Palatin Technologies Inc | 9.827M |
| iBio Inc | 25.29M |
| Theriva Biologics Inc | 14.61M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 629.88M |
| Shareholders Equity (Quarterly) | 600.56M |
| Current Ratio | 32.65 |